The present work demonstrated that the single administration of DCs transduced for the production of IL-12 and/or IL-18 increases the influx and activity of CD4+ and CD8+ T lymphocytes and decreases CD11b cells into the tumor microenvironment. This evidence concerns the gene IL18 and neoplasm.